Spring direct naar de hoofdnavigatie of de inhoud

Erik Jan Lindeboom

Patent attorney

“We think we have solved the mystery of creation. Maybe we should patent the universe and charge everyone royalties for their existence. (Stephen Hawking)”
Home / Experts / Erik Jan Lindeboom

Erik Jan Lindeboom

Erik Jan Lindeboom

  • Chemistry
  • Trainee Patent Attorney

Erik Jan Lindeboom studied synthetic chemistry at the Hogeschool van Leiden. For his Bachelor’s research he worked on the synthesis of tubulin-binding oryzalin derivatives the University of California, Irvine, where he was primarily responsible for improving the synthetic route to access oryzalin derivatives.

More information about Erik Jan

After receiving his BSc in applied science in 2007, he started working at Syncom BV, performing contract research in organic chemistry. In 2013, he finished his PhD at the Australian National University (ANU) in Canberra, after which he continued to work at ANU. From here he took a position at the the Rijksuniversity of Groningen in  2014 as a labmanager for all the organic research groups.  In 2015, Erik Jan worked on a project at ANU, after which  he took a position at Greatcell Solar in Queanbeyan, Australia.  Over the years he gained an interest in patent applications and infringements. In 2017, he  started to work as a trainee patent attorney at V.O.

Education

  • PhD in Organic Synthesis, Australian National University, Australia, 2014
  • BSc in Applied Chemistry, College of Leiden, the Netherlands, 2007

Publications

  • Synthesis of Ene-yne-enes by Nickel-Catalyzed Double SN2’ substitution of 1,6-Dichlorohexa-2,4-diyne (Gongbao Wang, Erik Jan Lindeboom, Chris van Heerewaarden, Adriaan J. Minnaard, Catal. Sci. Technol. 2017, accepted)
  • Occurrence and significance of phytanyl arenes across the Permian-Triassic boundary interval, (Hendrik Grotheer, Pierre LeMétayer, Matthew J. Piggot, Erik Jan Lindeboom, Alex I. Holman, Richard J. Twichett, Kliti Grice Org. Geochem. 2017, 104, 42)
  • [5]radialene (Emily G. Mackay, Christopher G. Newton, Henry Toombs-Ruane, Erik Jan Lindeboom, Thomas Fallon, Anthony C. Willis, Michael N. Paddon-Row, and Michael S. Sherburn, J. Am. Chem. Soc. 2015, 137, 14653) – featured on the cover
  • Tetravinylethylene, (Erik Jan Lindeboom, Michael N. Paddon-Row, and Michael S. Sherburn, Angew. Chem. Int. Ed., 2014, 53, 5440). This article was highlighted in Nat. Chem., 2014, 6, 558 and Synfacts., 2014, 7, 701
  • Computational and Synthetic Studies with Tetravinylethylenes, (Erik Jan Lindeboom, Michael N. Paddon-Row, and Michael S. Sherburn J. Org. Chem., 2014, 79, 11496)

Languages

  • Dutch
  • English

 

Also see these experts

Jennifer Ebner von Eschenbach

  • European Patent Attorney
  • Senior Associate

Michiel Dokter

  • European Patent Attorney
  • Dutch Patent Attorney
  • Associate
More experts

News

No happy ending for a pharmaceutical company in a case involving a Native American tribe

In the case known as Mohawk tribe versus Mylan, the US Federal Circuit Court of Appeals ruled that patent holders cannot shield themselves from an “inter partes review” of a patent by assigning that patent to a Native American tribe. Ironically enough, this is due to the fact that the decision handed down by the […]Continue reading

Does the new law for the protection of trade secrets offer sufficient protection?

On 9 June, the new law for the protection of trade secrets came into force (based on European Directive 2016/943/EU). On the basis of the law, it is possible to take action against the illegal acquisition, use and disclosure of trade secrets. If a trade secret is misused, the holder can bring various actions based […]Continue reading

V.O. supports Hartstichting

V.O. has become sponsor of the Hartstichting, the non-profit organisation that raises funds in the battle against cardiovascular disease. Annually, the Hartstichting invests millions of euros in scientific research. The collaboration focuses primarily on advice and information relating to intellectual property law, and making agreements in this regard with researchers.Continue reading

Events

European Biotech and Pharma Partnering Conference 2018

Osaka, Japan,Congres Convention Centre Second Basement, North Building, Grand Front Osaka

The European Biotech and Pharma Partnering Conference in Osaka offers business contacts to industry professionals who are looking for potential partners in the EU and Japan to ensure sustainable business development and growth. More about this event

The London IP Summit 2018

Four Seasons Hotel London at Park Lane, Hamilton Place, Park Lane, London, Verenigd Koninkrijk

The London IP Summit is an industry leading event dedicated to bringing together IP owners, experts and investors to address key challenges and operational issues faced by companies and IP professionals today. More about this event

IPPLA 3rd Annual Meeting 2018

Omni Hotel, California Street, San Francisco, Californië, USA

Annual Meeting of International Intellectual Property Law Association, Inc. (IIPLA) is the leading event in the West USA. Attended by hundreds of participants from more than 35+ countries. More about this event